Leaving Nothing Behind: Bioresorbable Vascular Scaffolds for Femoropopliteal Disease

Affiliations

¹ Division of Cardiovascular Medicine, The Vascular Center, University of California, Davis, Medical Center, Sacramento, California. Electronic address: jrlaird@ucdavis.edu.
² Division of Cardiovascular Medicine, The Vascular Center, University of California, Davis, Medical Center, Sacramento, California.

Free article

Editorial

John R Laird et al. JACC Cardiovasc Interv. 2016.

Free article

. 2016 Jun 13;9(11):1188-90.

doi: 10.1016/j.jcin.2016.04.002.

¹ Division of Cardiovascular Medicine, The Vascular Center, University of California, Davis, Medical Center, Sacramento, California. Electronic address: jrlaird@ucdavis.edu.
² Division of Cardiovascular Medicine, The Vascular Center, University of California, Davis, Medical Center, Sacramento, California.

No abstract available

Keywords: bioresorbable vascular scaffold; femoropopliteal; peripheral artery disease.

Comment on

Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging Results.
Lammer J, Bosiers M, Deloose K, Schmidt A, Zeller T, Wolf F, Lansink W, Sauguet A, Vermassen F, Lauwers G, Scheinert D, Popma JJ, McGreevy R, Rapoza R, Schwartz LB, Jaff MR. Lammer J, et al. JACC Cardiovasc Interv. 2016 Jun 13;9(11):1178-87. doi: 10.1016/j.jcin.2016.02.051. JACC Cardiovasc Interv. 2016. PMID: 27282601 Clinical Trial.